Related Experiment Video
Updated: Apr 29, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Longitudinal stability of specific barriers to medication adherence
Jennifer L Lee1, Cyd Eaton2, Ana M Gutiérrez-Colina2
1Department of Psychology, University of Georgia, Department of Medicine, Division of Population Sciences, Rutgers Cancer Institute of New Jersey, Center for Pain and the Brain, Children's Hospital Boston/Harvard Medical School, and Department of Psychiatry and Behavioral Sciences, Children's Healthcare of Atlanta, Transplant Services/Emory University School of Medicine jenlee09@gmail.com.
Specific barriers to medication adherence in pediatric transplant patients remain stable over 18 months. These challenges likely persist without targeted interventions, impacting long-term health outcomes.
Area of Science:
- Pediatric Transplant Medicine
- Adherence Research
- Health Psychology
Background:
- Barriers to medication adherence negatively impact pediatric transplant recipients' outcomes.
- While total barriers may be stable, specific barriers require further investigation over time.
Purpose of the Study:
- To examine the frequency and stability of specific medication adherence barriers in pediatric transplant recipients over 18 months.
Main Methods:
- 63 parents and 51 adolescents/young adults from kidney, liver, heart, and lung transplant cohorts participated.
- Perceived barriers to adherence were assessed at two time points, 18 months apart.
Main Results:
- Most parent- and adolescent-reported specific barriers demonstrated stability between the two assessment periods.
- Few specific barriers showed significant changes in endorsement levels over the 18-month study duration.
Conclusions:
- Specific barriers to medication adherence in pediatric transplant patients are generally stable over time.
- Interventions are likely necessary to modify these persistent barriers and improve patient outcomes.
Related Concept Videos
Longitudinal Studies
Drug Therapy
Antianxiety Medications
Longitudinal Research
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
